← Browse by Condition
Medical Condition
hairy cell leukemia
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 1, Phase 2
NCT04775745 Phase 1
Recruiting
Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.
Enrollment
60 pts
Location
United States
Sponsor
Newave Pharmaceutical Inc
NCT06561360 Phase 2
Recruiting
A Study of Vemurafenib and Obinutuzumab Compared to Cladribine and Rituximab in People With Hairy Cell Leukemia (HCL)
Enrollment
86 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance...